本文選題：腸胃舒 + 膿毒癥��； 參考：《中國(guó)中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志》2016年11期

【摘要】：目的:觀察腸胃舒治療膿毒癥胃腸功能障礙的臨床療效。方法:50位觀察病例隨機(jī)數(shù)字表法分為對(duì)照組和腸胃舒組各25例。對(duì)照組給予西醫(yī)常規(guī)治療,腸胃舒組給予腸胃舒聯(lián)合西醫(yī)常規(guī)治療。治療7 d后,比較2組病人APACHEⅡ評(píng)分、胃腸功能障礙評(píng)分及MODS發(fā)生率和病死率。結(jié)果:治療后2組病人的APACHEⅡ評(píng)分、胃腸功能障礙評(píng)分均降低,但腸胃舒組降低程度更加明顯,腸胃舒組病人的MODS發(fā)生率和病死率均低于對(duì)照組。結(jié)論:腸胃舒能夠改善膿毒癥胃腸功能障礙患者的胃腸功能狀態(tài),降低MODS發(fā)生率和病死率,改善患者預(yù)后,為臨床治療提供新的方法。
[Abstract]:Objective: to observe the clinical effect of Changwei Shu on gastrointestinal dysfunction of sepsis. Methods 50 observed cases were randomly divided into two groups: control group (n = 25) and Changwei Shu group (n = 25). The control group was treated with routine western medicine, and the control group was treated with routine western medicine. After 7 days of treatment, Apache 鈪，

本文編號(hào)：2005096